StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

EBS — Emergent BioSolutions Inc.

EXPENSIVE (MOS -32.0%) · Quality 43/100

Price
6.8
Intrinsic value
5.15
Margin of safety
-32.0%
Implied growth (reverse DCF)
+24.0%
model assumes +20.0%
Value Score
8
Quality
43
Psychology
-3.4
Discovery
25.7
price/volume attention only
Moat score
28
erosion: none

Value Score: bottom 11% of Russell 3000 · Quality: bottom 29%

Open the interactive Deep Dive for EBS →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/EBS - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is EBS undervalued?

As of 2026-09-19, EBS trades at 6.8 against a computed intrinsic value of 5.15 (-32.0% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Emergent BioSolutions Inc.'s Value Score?

Emergent BioSolutions Inc.'s Value Score is 8 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.